For research use only. Not for therapeutic Use.
GPR52 antagonist-1 (Compound 43) is a GPR52 antagonist with an IC50 of 0.63 μM. GPR52 antagonist-1 reduces mHTT (mutant huntingtin protein) levels by targeting GPR52 and promotes survival of mouse primary striatal neurons[1].
GPR52 antagonist-1 (Compound 43) (5 mg/kg; i.p.; once a day for 4 weeks) reduces mHTT levels and rescues HD-related phenotypes in HdhQ140 mice[1].
Catalog Number | I025081 |
CAS Number | 1239987-91-7 |
Synonyms | (E)-5-phenyl-1-thiophen-2-ylpent-2-en-1-one |
Molecular Formula | C15H14OS |
Purity | ≥95% |
InChI | InChI=1S/C15H14OS/c16-14(15-11-6-12-17-15)10-5-4-9-13-7-2-1-3-8-13/h1-3,5-8,10-12H,4,9H2/b10-5+ |
InChIKey | XUIAIACHIPOOHR-BJMVGYQFSA-N |
SMILES | C1=CC=C(C=C1)CCC=CC(=O)C2=CC=CS2 |
Reference | [1]. Wang C, et al. GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington’s Disease-Related Phenotypes. J Med Chem. 2021 Jan 28;64(2):941-957. |